Inspired by natural biology, cell membrane-mimetic surface engineering and cell membrane
camouflaging technology have been widely investigated. Notably, the cell membrane …

Unpredictable and uncontrollable protein adsorption on nanoparticles remains a
considerable challenge to achieving effective application of nanotechnologies within …

Tumor heterogeneity, often leading to metastasis, limits the development of tumor therapy.
Personalized therapy is promising to address tumor heterogeneity. Here, a vesicle system …

Abstract Intracellular Methicillin-Resistant Staphylococcus aureus (MRSA) remains a major
factor of refractory and recurrent infections, which cannot be well addressed by antibiotic …

In the last decades, many nanovectors were developed for different diagnostic or therapeutic
purposes. However, most nanosystems have been designed using a “bottom-up” approach …

Background Melanoma is the most common symptom of aggressive skin cancer, and it has
become a serious health concern worldwide in recent years. The metastasis rate of …

Immunostimulatory agents, including adjuvants, cytokines, and monoclonal antibodies, hold
great potential for the treatment of cancer. However, their direct administration often results …

Achieving precise cancer theranostics necessitates the rational design of smart
nanosystems that ensure high biological safety and minimize non-specific interactions with …

Although nanocarriers offer many advantages as drug delivery systems, their poor stability in
circulation, premature drug release and nonspecific uptake in non-target organs have …

Erythrocytes are the most abundant cells in the blood. As the results of long‐term natural
selection, their specific biconcave discoid morphology and cellular composition are …